TY  - JOUR
T1  - SARS-CoV-2 as Emerging Disease: Preventive Instructions and Review of Literature
AU - Hadi Karbalaie Niya, Mohammad AU - Chenari, Maryam AU - Karimi, Zeinab 
JO  - International Journal of Tropical Medicine
VL  - 15
IS  - 4
SP  - 103
EP  - 108
PY  - 2020
DA  - 2001/08/19
SN  - 1816-3319
DO  - ijtmed.2020.103.108
UR  - https://makhillpublications.co/view-article.php?doi=ijtmed.2020.103.108
KW  - SARS-CoV-2
KW  -immunity
KW  -instructions
KW  -preventive
KW  -vaccine
AB  - In late December, 2019, a novel coronavirus
was first reported in Wuhan, named as SARS-CoV-2
caused a series of acute atypical respiratory diseases. To
date, virus has infected >9 million people and almost
630,193 death that is estimated about 6% it mainly
transmitted through contaminated respiratory droplets
between people. So far, many hypotheses have been put
forward about how the virus originated but here on theory
about the origin of the virus as a result of mutation and
natural selection will be discussed. Right now there is
not enough information to make sure that weather
recovery from COVID-19 is safe or immunity does
provide long-term protection against COVID-19. The
persistence of the virus has been investigated at various
surfaces. Many companies are trying to make a vaccine
for this virus, so that, the Moderna American company
has been able to get the approval of three phases of
making the vaccine. In this review we tried to
introduce the SARS-CoV-2 and review the preventive
instructions and related literature.
ER  -